These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8946838)

  • 1. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.
    Albini A; Soldi R; Giunciuglio D; Giraudo E; Benelli R; Primo L; Noonan D; Salio M; Camussi G; Rockl W; Bussolino F
    Nat Med; 1996 Dec; 2(12):1371-5. PubMed ID: 8946838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein.
    Rusnati M; Urbinati C; Musulin B; Ribatti D; Albini A; Noonan D; Marchisone C; Waltenberger J; Presta M
    Endothelium; 2001; 8(1):65-74. PubMed ID: 11409852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.
    Ganju RK; Munshi N; Nair BC; Liu ZY; Gill P; Groopman JE
    J Virol; 1998 Jul; 72(7):6131-7. PubMed ID: 9621077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
    Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
    Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
    J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
    Wang H; Keiser JA
    Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1.
    Mitola S; Sozzani S; Luini W; Primo L; Borsatti A; Weich H; Bussolino F
    Blood; 1997 Aug; 90(4):1365-72. PubMed ID: 9269752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
    Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.